Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Plasma cell 1Lymphoid 1Dermatologic 1

Conditions

Sarcoma 19Neoplasms 7Osteosarcoma 5Gastrointestinal Stromal Tumors 4Neuroblastoma 3Melanoma 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Lymphoma 2Lung Neoplasms 2Glioma 2Esophageal Neoplasms 2Desmoid Tumors 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Wilms Tumor 1Uveal Melanoma 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Skin Neoplasms 1Sarcoma, Myeloid 1Sarcoma, Ewing 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplastic Cells, Circulating 1

Interventions

pembrolizumab 3Oncolytic Virotherapy 2Fluorouracil 2Cyclophosphamide 2Cetuximab 2trebananib 1spartalizumab 1repotrectinib 1pemigatinib 1patritumab 1fludarabine phosphate 1fludarabine 1etoposide phosphate 1darinaparsin 1apatinib 1Tetanus Toxoid 1Sirolimus 1Paclitaxel 1Mesna 1Ipilimumab 1Injections 1Etoposide 1Cisplatin 1Celecoxib 1Carboplatin 1Blood Specimen Collection 1Ascorbic Acid 12,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Blood Specimen Collection × Sarcoma × Clear all
NCT01916135 2020-04-27

PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
11 enrolled
DermatologicLymphoidPlasma cellSarcoma

Carcinoma, Lymphoma, Melanoma, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡